TPN/Central Line Care. Objective One Demonstrate safe administration and discontinuation of TPN.
-
Upload
marshall-greene -
Category
Documents
-
view
231 -
download
4
Transcript of TPN/Central Line Care. Objective One Demonstrate safe administration and discontinuation of TPN.
Parenteral Nutrition*Parenteral nutrition = intravenous delivery of
nutrition via central venous catheter (CVC)Indicated for clients who can not ingest food or
fluids through the GI tractTypes of parenteral nutrition include partial or
totalPartial parenteral nutrition (PPN) is indicated for
clients who can meet some of their nutritional requirements orally (i.e. shortened small bowel due to injury/disease)
Total parenteral nutrition (TPN) is required for severely malnourished clients, clients with severe and extensive burns or other trauma, and for GI recovery
Administered via central line into high-flow vein to prevent vessel damage due to hypertonicity
Total Parenteral NutritionContains amino acids, vitamins, minerals,
and trace elementsCan be modified to meet nutritional needs of
clientHigh in glucose
10-50% dextrose in waterStart infusion slowly to prevent hyperglycemia
Less than 30-60 mL/h Most TPN solutions contain insulin to aid in absorption
Do not increase rate without an order as this can cause osmotic diuresis and dehydration
Clients on TPN must receive concurrent weekly infusions of lipids w/fatty acids and triglycerides
TPN (cont’d)Prepared under strict asepsis procedures
Use surgical aseptic technique when changing TPN solution and tubing
Do not use TPN infusion line for administering other medications/solutions to prevent contamination
Formula bottles should hang for no longer than 12 hours to prevent complications
TPN formula adjusted based on client’s statusWeightLab values (electrolytes, blood sugar, albumin,
BUN, creatinine)TPN therapy must be discontinued gradually
(up to 48 hours) to prevent sudden drop in blood sugar
Central Line Dressing ChangeSupine position with client’s head turned
away from CVC siteDon gloves and mask; place mask on
clientRemove and dispose of old central line
dressing and glovesInspect siteRemove and dispose of maskAccess sterile CVC dressing change kitApply sterile gloves and maskCleanse site with 2% chlorhexidine
moving in a spiral direction; allow to dryMaintain sterility
CVC Dressing Change (cont’d)Apply dressing
Sterile gauzeSterile, transparent, semipermeable dressingChange CVC dressing every 7 daysReplace dressing if damp, loosened, or visibly soiled
For PICC line, check position with each dressing change to ensure proper placementIf PICC line position has changed more than 1-2 cm
since insertion, may need to x-ray chest for placement
*Changing central line caps --Prime new sterile caps with saline via sterile
syringeAssure all lumen are clampedClean existing caps with alcohol prior to
removal
Changing Central Line Caps (cont’d)
Clamp or kink central line prior to removing caps to prevent air from entering the line
Remove first central line cap and replace with primed cap, maintaining sterility; repeat for all caps, ensuring each is secure
Flush central line per institutional protocol to maintain patency and prevent occlusionNever use syringe with a barrel capacity of less
than 10mL Smaller syringes generate more pressure than larger
ones, potentially damaging the lineFlush with at least 10mL normal saline (NS)
whenever the central line is irrigatedUse push-pause flushing method to remove
particles that adhere to the catheter lumen
*Intralipids are a source of essential fatty acids and energy
Fat emulsion must be included in longer-term TPN therapy in order to deliver adequate calories and high levels of essential fatty acidsTypically initiated within 1 week of TPN therapy
Change tubing every 12 hoursInfuse or discard emulsion within 12 hours
of hanging the containerBegin infusion slowly, increasing daily
based on client’s tolerancePotential for adverse reaction, fat embolus
w/rapid infusion
*Removal of nontunneled, noncuffed central lines is an aseptic technique that can be performed by the RN
Place client in recumbent positionRemove dressing and any securing devices from
the central line insertion siteInstruct client to perform the Valsalva maneuver
Air is prevented from entering the catheter wound and pathway while client is bearing down
Remove the catheter and apply pressure to the site
Immediately apply antiseptic ointment and sterile occlusive dressing
Client remains recumbent and inactive for 30 minutes
Measure catheter length, document integrity
*Indications for placement of a central venous access device (CVAD) include --Inadequate peripheral vascular accessNeed for frequent vascular accessHypertonic/hyperosmolar infusionsInfusion of irritating or vesicant drugsRapid absorption and blood/tissue perfusionLong-term IV therapy
*Contraindications for CVAD placement --Altered skin integrity,Anomalies of the central vasculature, superior
vena cava syndromeCancer at the base of the neck or the apex of
the lungImmunosuppression, septicemia
*Main types of CVADs --Nontunneled cathetersTunneled cathetersPeripherally inserted central catheters (PICC)Implanted ports
Nontunneled catheters are inserted into the superior vena cava via percutaneous stick through the subclavian or jugular veinSingle or multilumenMay be referred to as a percutaneous central
venous catheterExample is a Hohn catheterCatheter size ranges from 24 gauge and 3 ½
inches to 14 gauge and 12 inches
Tunneled catheters are inserted via percutaneous cutdown under anesthesiaInsertion and removal performed by a
physicianCatheter tip is placed in the superior vena
cava while the other end is tunneled subcutaneously to an incisional exit site on the trunk of the body
Single or multilumenDacron cuff near exit site anchors catheter in
place, acts a securing device, and serves as a microbial barrier
Left in place for indefinite period of timeExamples are the Broviac, Hickman, and
Groshong
PICCs are typically placed in the basilic vein due to diameter and straighter path to the superior vena cava Single or multilumenMay be placed by RNUsual dwelling time is 1-12 weeks (can stay much
longer)Decreases risk of CVC complications
*A midline catheter (MLC) is a percutaneously inserted IV line that is placed between the antecubital fossa and the head of the clavicle, then advanced into the larger vessels below the axillaDwelling time is 1 to 6 weeksCan deliver most infusates except caustic drugs and
TPN that need the dilution capabilities of the superior vena cava
May be placed by RN
An implanted port, or vascular access port (VAP), is surgically inserted into a subcutaneous pocket under the skin without any portion of the system exiting the bodySingle or double injection portConnected to a catheter positioned in the superior
vena cavaPort access must be with a noncoring needle to
avoid damaging the system Huber needle Port-a-Cath Gripper needle
Useful for long-term infusion therapy; should not be accessed more than every 1-3 weeks
Eliminates need for exit site care/dressing changes or regular flushing if not in use; reduces risk for infection
Contraindicated in patients with septicemia or bacteremia
*Risks/complications of CVADs --Pneumothorax (due to close proximity to lung
apex)Laceration of the subclavian artery
Difficult to control bleeding because this is a noncompressible vessel
HemothoraxMigration of the catheter tip across the sinoatrial
(SA) node Dysrhythmia
May become trapped in the tricuspid valve Permanent damage of the valve Requires valve replacement
Air or catheter embolismCatheter pinch-off = the anatomic compression of
a CVAD between the clavicle and first rib Intermittent occlusion of central line Catheter fracture